5.78
price up icon0.87%   0.05
pre-market  プレマーケット:  5.79   0.010   +0.17%
loading
前日終値:
$5.73
開ける:
$5.53
24時間の取引高:
639.21K
Relative Volume:
0.65
時価総額:
$267.76M
収益:
$20.72M
当期純損益:
$-100.84M
株価収益率:
-2.1729
EPS:
-2.66
ネットキャッシュフロー:
$-78.56M
1週間 パフォーマンス:
+28.44%
1か月 パフォーマンス:
+46.33%
6か月 パフォーマンス:
-3.18%
1年 パフォーマンス:
-60.71%
1日の値動き範囲:
Value
$5.4204
$5.845
1週間の範囲:
Value
$4.99
$6.69
52週間の値動き範囲:
Value
$2.235
$17.41

4 D Molecular Therapeutics Inc Stock (FDMT) Company Profile

Name
名前
4 D Molecular Therapeutics Inc
Name
セクター
Healthcare (1158)
Name
電話
(510) 505-2680
Name
住所
5858 HORTON STREET #455, EMERYVILLE
Name
職員
227
Name
Twitter
Name
次回の収益日
2024-12-13
Name
最新のSEC提出書
Name
FDMT's Discussions on Twitter

FDMT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
FDMT
4 D Molecular Therapeutics Inc
5.78 265.44M 20.72M -100.84M -78.56M -2.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
375.63 98.88B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
559.80 58.84B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
435.10 56.12B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
672.35 41.20B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
298.29 35.49B 3.81B -644.79M -669.77M -6.24

4 D Molecular Therapeutics Inc Stock (FDMT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-13 ダウングレード BMO Capital Markets Outperform → Market Perform
2024-11-21 開始されました Morgan Stanley Underweight
2024-09-23 ダウングレード Cantor Fitzgerald Overweight → Neutral
2024-04-15 開始されました Barclays Overweight
2024-02-07 再開されました Goldman Buy
2023-10-26 開始されました RBC Capital Mkts Outperform
2023-10-24 開始されました Cantor Fitzgerald Overweight
2023-10-18 アップグレード Leerink Partners Market Perform → Outperform
2023-07-05 開始されました Chardan Capital Markets Buy
2023-01-30 開始されました BMO Capital Markets Outperform
2022-11-18 開始されました H.C. Wainwright Buy
2022-11-15 アップグレード Goldman Neutral → Buy
2022-08-12 ダウングレード SVB Leerink Outperform → Mkt Perform
2022-06-22 開始されました Jefferies Buy
2022-01-04 開始されました SVB Leerink Outperform
2021-01-05 開始されました BofA Securities Buy
2021-01-05 開始されました Evercore ISI Outperform
2021-01-05 開始されました Goldman Neutral
すべてを表示

4 D Molecular Therapeutics Inc (FDMT) 最新ニュース

pulisher
04:15 AM

Will earnings trigger a reversal in 4D Molecular Therapeutics Inc.Volume Spike Detection for Early Breakouts - Newser

04:15 AM
pulisher
04:13 AM

Heatmap analysis for 4D Molecular Therapeutics Inc. and competitors7-Day Equity Return Range Forecast Model - Newser

04:13 AM
pulisher
02:19 AM

Can you recover from losses in 4D Molecular Therapeutics Inc.Watchlist Summary for Active Day Traders - Newser

02:19 AM
pulisher
Aug 07, 2025

What makes 4D Molecular Therapeutics Inc. stock attractive to long term investorsFree Real Market Momentum Signal Generator - Newser

Aug 07, 2025
pulisher
Aug 07, 2025

Published on: 2025-08-07 03:01:11 - Newser

Aug 07, 2025
pulisher
Aug 07, 2025

4D Molecular Therapeutics (FDMT) to Release Earnings on Thursday - Defense World

Aug 07, 2025
pulisher
Aug 06, 2025

4D Molecular Therapeutics shares fall 2.73% intraday after announcing participation in H.C. Wainwright 5th Annual Ophthalmology Virtual Conference. - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Volatility clustering patterns for 4D Molecular Therapeutics Inc.Short-Term Sector Movement Forecast Generator - Newser

Aug 06, 2025
pulisher
Aug 05, 2025

Using fundamentals and technicals on 4D Molecular Therapeutics Inc.AI Volatility Forecast and Risk Monitor - Newser

Aug 05, 2025
pulisher
Aug 04, 2025

Developing predictive dashboards with 4D Molecular Therapeutics Inc. dataEquity Portfolio Outlook and Performance Summary - Newser

Aug 04, 2025
pulisher
Aug 04, 2025

4D Molecular Therapeutics Inc expected to post a loss of 88 cents a shareEarnings Preview - TradingView

Aug 04, 2025
pulisher
Aug 04, 2025

How to build a custom watchlist for 4D Molecular Therapeutics Inc.Entry Opportunity Screener with Confirmation - Newser

Aug 04, 2025
pulisher
Aug 04, 2025

Fibonacci Support Holding Strong in 4D Molecular Therapeutics Inc.Conservative Long Term Growth Plans Under Review - beatles.ru

Aug 04, 2025
pulisher
Aug 04, 2025

Why is 4D Molecular Therapeutics Inc. stock attracting strong analyst attentionAchieve consistent profits with proven methods - Jammu Links News

Aug 04, 2025
pulisher
Aug 04, 2025

4D Molecular Therapeutics’ (FDMT) Buy Rating Reiterated at Chardan Capital - Defense World

Aug 04, 2025
pulisher
Aug 03, 2025

Is 4D Molecular Therapeutics Inc. a growth stock or a value stockProven strategies for superior portfolio growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of 4D Molecular Therapeutics Inc. stockGet daily expert analysis on top stocks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is 4D Molecular Therapeutics Inc. Stock a Good Fit for Conservative InvestorsFree Capital Preserving Trade Plan Templates - Newser

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in 4D Molecular Therapeutics Inc. stockExplosive capital gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are 4D Molecular Therapeutics Inc. company’s key revenue driversCapitalize on fast-growing investment opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Does 4D Molecular Therapeutics Inc. stock perform well during market downturnsRapid profit acceleration - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Is 4D Molecular Therapeutics Inc. stock overvalued or undervaluedInvest smarter with data-backed trading alerts - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are the technical indicators suggesting about 4D Molecular Therapeutics Inc.Spectacular growth rates - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

When is 4D Molecular Therapeutics Inc. stock expected to show significant growthMassive stock growth - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Why 4D Molecular Therapeutics Inc. stock attracts strong analyst attentionFree Low Risk Swing Trade Opportunity List - Newser

Aug 02, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics Inc. stock prediction for this weekLow Drawdown Picks with Weekly Updates - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics Showcases Positive Trial Results, Charts New Growth Trajectory - timothysykes.com

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular (FDMT) Stock Climbs Following Promising Retina Therapy Data - Stocks Telegraph

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics Rallies On Heels Of Diabetes-Related Vision Study - 富途牛牛

Aug 01, 2025
pulisher
Aug 01, 2025

How volatile is 4D Molecular Therapeutics Inc. stock compared to the marketEntry Signal Forecasts With Low Risk - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular: Time to Buy After Recent Surge? - StocksToTrade

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics: A Market Shift? - timothysykes.com

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics shares rise 30.44% premarket after presenting positive 60-week results for 4D-150. - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

Chardan Capital Maintains Buy on 4D Molecular, Raises PT to $25 - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics stock soars after positive DME trial results By Investing.com - Investing.com Canada

Aug 01, 2025
pulisher
Aug 01, 2025

Will a bounce in 4D Molecular Therapeutics Inc. offer an exitPrice Action Trading with Volume Confirmation - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics Shares Surge 50.89% on Positive Clinical Trial Results - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics (FDMT) Shares Soar 37.78% on Positive Clinical Trial Results - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics shares rise 56% premarket after presenting positive 60-week results for 4D-150. - AInvest

Aug 01, 2025
pulisher
Jul 31, 2025

4D Molecular (FDMT) Shows Promising Results in Clinical Trial fo - GuruFocus

Jul 31, 2025
pulisher
Jul 31, 2025

4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update - GlobeNewswire

Jul 31, 2025
pulisher
Jul 31, 2025

How does 4D Molecular Therapeutics Inc. compare to its industry peersBeginner Investor Strategy With Proven Results - Jammu Links News

Jul 31, 2025
pulisher
Jul 30, 2025

Trend Reversal Possible in 4D Molecular Therapeutics Inc. Charts IndicateEarnings Play Trade Plan With Alerts Shared - beatles.ru

Jul 30, 2025
pulisher
Jul 30, 2025

Advanced analytics toolkit walkthrough for 4D Molecular Therapeutics Inc.Real Time Trade Execution Alert Plan - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Weiss Ratings Reiterates Sell (D-) Rating for 4D Molecular Therapeutics (NASDAQ:FDMT) - Defense World

Jul 30, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 16:44:26 - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

How 4D Molecular Therapeutics Inc. stock performs during market volatilityPortfolio Positioning Strategy With Timing - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

What makes 4D Molecular Therapeutics Inc. stock price move sharplyMinimal Risk Growth Investment Opportunity Analysis - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

4D Molecular Therapeutics Bets Big On Gene Therapy Breakthroughs - Finimize

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 09:03:48 - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-29 02:38:48 - metal.it

Jul 28, 2025

4 D Molecular Therapeutics Inc (FDMT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$78.20
price up icon 0.71%
$37.01
price down icon 0.30%
$109.30
price down icon 1.76%
$28.07
price down icon 1.58%
$111.35
price up icon 0.04%
biotechnology ONC
$298.29
price down icon 0.08%
大文字化:     |  ボリューム (24 時間):